Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8837136 | Surgery | 2018 | 6 Pages |
Abstract
This first large national study suggests that multimodal therapy is independently associated with improved survival for both AYAs and adults with rhabdomyosarcoma, similar to pediatric patients, but multimodal therapy is appreciably underused. Implementation of multimodal therapy for all patients could potentially improve overall outcomes of patients with rhabdomyosarcoma.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Trevan D. Fischer, Shrawan G. Gaitonde, Bradley C. Bandera, Mehul V. Raval, Sanjeev A. Vasudevan, Kenneth W. Gow, Elizabeth A. Beierle, John J. Doski, Adam B. Goldin, Monica Langer, Jed G. Nuchtern, Stacey Stern, Leland J. Foshag, Melanie Goldfarb,